Systemic mastocytosis (SM) includes indolent systemic mastocytosis (ISM); systemic mastocytosis with an associated hematologic clonal, nonmast cell lineage disease (SM-AHNMD); aggressive systemic ...

Cogent Biosciences' uncertain competitive edge may compel investors to sit on the sidelines. Read more about the cautious ...

The following is a summary of “Comparison of prognostic scores according to WHO classification in 170 patients with advanced mastocytosis and C-finding treated with midostaurin,” published in the ...

Blueprint Medicines' AYVAKIT continues to gain traction among key stakeholders. See more on BPMC stock and the factors ...

Allakos (ALLK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Jonathan ...

After hours: September 30 at 7:36 PM EDT Loading Chart for BPMC ...

In the final episode, experts at UCSD and La Jolla Institute discuss current clinical trials of a cancer vaccine and future directions for neoantigen vaccines. Custom-made Cancer Therapy ...

Mehta A, Popplewell L, Collins GP, et al. Magrolimab plus rituximab in relapsed/refractory indolent non-hodgkin lymphoma: phase 1/2 trial 3-year follow-up. Blood Adv . Published online August 30 ...

We want to support clinicians in ensuring all patients are fully informed when consenting to SACT. These forms are endorsed by the UK Systemic Anti-Cancer Therapy Board (UK SACT Board). Who has ...

France’s Council of State rejects contention by campaigners that racial profiling by police is systemic Local grassroots organizations and international rights groups had hoped that a favorable ...